Bank of New York Mellon’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-928,279
Closed -$3.53M 4197
2020
Q1
$3.53M Sell
928,279
-65,380
-7% -$282K ﹤0.01% 2256
2019
Q4
$5.06M Sell
993,659
-136,434
-12% -$722K ﹤0.01% 2340
2019
Q3
$5.71M Sell
1,130,093
-41,180
-4% -$205K ﹤0.01% 2216
2019
Q2
$7.23M Buy
1,171,273
+7,574
+0.7% +$36.5K ﹤0.01% 2150
2019
Q1
$5.4M Buy
1,163,699
+6,820
+0.6% +$30.9K ﹤0.01% 2296
2018
Q4
$4.86M Sell
1,156,879
-3,663
-0.3% -$18.7K ﹤0.01% 2311
2018
Q3
$7.28M Buy
1,160,542
+97,561
+9% +$749K ﹤0.01% 2211
2018
Q2
$8.55M Buy
1,062,981
+24,073
+2% +$184K ﹤0.01% 2102
2018
Q1
$7.75M Sell
1,038,908
-1,720
-0.2% -$11.4K ﹤0.01% 2119
2017
Q4
$6.19M Sell
1,040,628
-17,976
-2% -$109K ﹤0.01% 2241
2017
Q3
$7.79M Sell
1,058,604
-13,220
-1% -$84K ﹤0.01% 2118
2017
Q2
$7.28M Sell
1,071,824
-26,742
-2% -$197K ﹤0.01% 2135
2017
Q1
$10.4M Buy
1,098,566
+526,905
+92% +$5.26M ﹤0.01% 1950
2016
Q4
$4.94M Buy
571,661
+34,531
+6% +$255K ﹤0.01% 2320
2016
Q3
$3.4M Sell
537,130
-21,924
-4% -$133K ﹤0.01% 2434
2016
Q2
$2.36M Buy
559,054
+2,357
+0.4% +$11.4K ﹤0.01% 2611
2016
Q1
$2.43M Buy
556,697
+1,337
+0.2% +$5.95K ﹤0.01% 2548
2015
Q4
$3.4M Sell
555,360
-83,800
-13% -$549K ﹤0.01% 2410
2015
Q3
$3.66M Buy
639,160
+105,074
+20% +$806K ﹤0.01% 2411
2015
Q2
$3.98M Buy
534,086
+58,709
+12% +$355K ﹤0.01% 2507
2015
Q1
$2.84M Sell
475,377
-3,209
-0.7% -$20.2K ﹤0.01% 2625
2014
Q4
$3.62M Buy
478,586
+110,284
+30% +$660K ﹤0.01% 2486
2014
Q3
$1.91M Buy
368,302
+39,177
+12% +$195K ﹤0.01% 2921
2014
Q2
$1.42M Sell
329,125
-30,968
-9% -$118K ﹤0.01% 3111
2014
Q1
$1.47M Buy
360,093
+57,344
+19% +$293K ﹤0.01% 3080
2013
Q4
$1.61M Sell
302,749
-25,376
-8% -$112K ﹤0.01% 3022
2013
Q3
$1.65M Buy
328,125
+52,893
+19% +$287K ﹤0.01% 2969
2013
Q2
$1.23M Buy
+275,232
New +$1.24M ﹤0.01% 3069

Other funds holding PGNX